| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.07 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.11 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.28 | 0.08 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |